SuicideNCT05991635
Evaluation of a Gatekeeper Training for Pharmacists
A study testing Gatekeeper training (e-learning) in people with Suicide, run by University Ghent at 1 site in Belgium.
Trial summary
This study aims to investigate to what extent a gatekeeper training (e-learning) for pharmacists and PTA is effective in changing the attitudes, knowledge, and self-efficacy. Moreover, it aims to examine how they evaluate the training and whether they were able to apply the learned skills in practice. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Suicide
- What is being tested?
- Gatekeeper training (e-learning)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 201 participants
- Where
- 1 siteBelgium
- Study dates
- 12 Apr 2023to 11 Jan 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- ≥ 18 years old
- Have access to internet
- Speak Dutch
- Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)
Who cannot join
- Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.
Trial locations and contacts
1 site in 1 country.
Belgium1 site
Flemish Centre of Expertise in Suicide Prevention, Ghent University
Ghent, 9000
About this study
This study aims to investigate to what extent a gatekeeper training (e-learning) for pharmacists and PTA is effective in changing the attitudes, knowledge, and self-efficacy. Moreover, it aims to examine how they evaluate the training and whether they were able to apply the learned skills in practice.
- Conditions
- Suicide
- Being tested
- Gatekeeper training (e-learning)
- Medical subject headings
- Suicide
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Gatekeeper training (e-learning)Behavioural
The gatekeeper training consists of an interactive e-learning (min. 1h, max. 3h) which includes theoretical knowledge, tips, exercises and relevant examples and cases. The main topics included in the e-learning are:
- Background information on suicide in Flanders (rates)
- Definitions and theoretical background (suicidal process, integrative explanatory model of suicide)
- Debunking existing myths about suicide
- The role of the pharmacist in suicide prevention
- Signal Recognition
- Talking about suicide and suicidal thoughts (start the conversation)
- How and to whom to refer as pharmacist or FTA
- Medication management and medication in the context of suicide
- Rights and obligations of a pharmacist/PTA in the context of suicide prevention
- Self-care
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Participants in this group (all participants) are asked to complete a questionnaire and then receive access to the online gatekeeper training (e-learning) during three days, after which they were asked to complete another questionnaire. After three months, a third questionnaire is sent. Receives: Behavioral: Gatekeeper training (e-learning) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in attitudes: Attitudes Towards Suicide Scale (ATTS)
The ATTS is a 37-item to be scored on a 5-point Likert scale (1= disagree completely to 5 = agree completely) to measure participants' attitudes towards suicide.
Measured: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Secondary outcomes (3)
Changes in self-efficacy: Measurement of Perceived Self-efficacy
The Measurement of Perceived Self-efficacy is a 10-item self-report questionnaire to be scored on a 4-point Likert scale (1= Completely false to 4 = completely true)
Measured: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Changes in perceptions/myths
Self-developped questionnaire: 4 statements to be rated as true or false; 2 question about how participant would feel if a patient said they have suicidal thouhgts
Measured: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Gatekeeper training evaluation
8 evaluative statements about the e-learning to be rated on a 5-point Likert scale (Totally disagree, disagree, neutral, agree, totally disagree).
Question to rate the e-learning on a scale of 1 (not good at all) to 10 (excellent) Additionally three open questions where participants can give feedback about what they liked/did not like/ general comments.
Measured: Post-test (after a week of access to e-learning)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2023
- Study start12 Apr 2023
- Primary completion11 Jan 2024
- Study completion11 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SuicideStudies of the same condition, open and under way.
- More trials run by University GhentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 201 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gwendolyn Portzky, Phd, Principal investigator, University Ghent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05991635
- Sponsor's protocol ID
- ONZ-2022-0598
- Status last verified
- Feb 2024
- First submitted
- 7 Aug 2023
- Last updated
- 6 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of a Gatekeeper Training for Pharmacists
- ClinicalTrials.gov ID
- NCT05991635
- Acronym / sponsor ID
- ONZ-2022-0598
- Conditions
- Suicide
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 201 participants (actual)
- Lead sponsor
- University GhentUniversity, hospital or other
- Study start
- 12 Apr 2023 (actual)
- Primary completion
- 11 Jan 2024 (actual)
- Study completion
- 11 Jan 2024 (actual)
- First posted
- 14 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate to what extent a gatekeeper training (e-learning) for pharmacists and PTA is effective in changing the attitudes, knowledge, and self-efficacy. Moreover, it aims to examine how they evaluate the training and whether they were able to apply the learned skills in practice.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: Gatekeeper training (e-learning)Participants in this group (all participants) are asked to complete a questionnaire and then receive access to the online gatekeeper training (e-learning) during three days, after which they were asked to complete another questionnaire. After three months, a third questionnaire is sent. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- ≥ 18 years old
- Have access to internet
- Speak Dutch
- Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)
Key exclusion criteria (1 listed)
- Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Gatekeeper training (e-learning)The gatekeeper training consists of an interactive e-learning (min. 1h, max. 3h) which includes theoretical knowledge, tips, exercises and relevant examples and cases. The main topics included in the e-learning are: * Background information on suicide in Flanders (rates) * Definitions and theoretical background (suicidal process, integrative explanatory model of suicide) * Debunking existing myths about suicide * The role of the pharmacist in suicide prevention * Signal Recognition * Talking about suicide and suicidal thoughts (start the conversation) * How and to whom to refer as pharmacist or FTA * Medication management and medication in the context of suicide * Rights and obligations of a pharmacist/PTA in the context of suicide prevention * Self-care | Behavioural | Intervention group |
Primary outcome
Changes in attitudes: Attitudes Towards Suicide Scale (ATTS)
Time frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
The ATTS is a 37-item to be scored on a 5-point Likert scale (1= disagree completely to 5 = agree completely) to measure participants' attitudes towards suicide.
3 secondary outcomes
Changes in self-efficacy: Measurement of Perceived Self-efficacy
Time frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Changes in perceptions/myths
Time frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Gatekeeper training evaluation
Time frame: Post-test (after a week of access to e-learning)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Feb 2024.
- Individual participant dataSharing planned: No
Related trials for Suicide
Active, not recruitingPhase 2/3
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Suicidal Ideation, Major Depressive Disorder
Recruiting
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
Suicide, Bereavement
Not yet recruitingPhase 2
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
PTSD, PTSD - Post Traumatic Stress Disorder
Not yet recruiting
Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide
Suicide, Mental Health Stigma
Not yet recruiting
BEAR for Women Who Have Experienced Sexual Assault and Have Suicidal Thoughts
Sexual Assault and Rape, Suicidal Thoughts
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gwendolyn Portzky, Phd principal investigator
University Ghent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Gatekeeper training (e-learning) in people with Suicide, run by University Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in attitudes: Attitudes Towards Suicide Scale (ATTS) (time frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2024.